Invesaro

Stocks Health care SRTA

NASDAQ · Health care

Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical, Inc. brought in $256M of revenue over the twelve months to June 30, 2026, up 136.1% from a year earlier. Net income was $40.2M, a net margin of 15.7%. In fiscal 2025 capital spending exceeded operating cash flow by $58.5M. At June 30, 2026 it held $16.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$5.33
+1.14% on the day · September 25, 2026
52-week range $3.95 to $6.50
Market cap
$471.5M
Revenue (last 12 months)
$256M
+136.1% year on year
Net margin
15.7%
P/E
10.7
on FY2025 diluted EPS

What Strata Critical Medical, Inc. does

Strata Critical Medical, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker SRTA.

Revenue and profit by year

Revenue
FY20: $23.4M $23.4M FY20FY21: $50.5M $50.5M FY21FY22: $146.1M $146.1M FY22FY23: $225.2M $225.2M FY23FY24: $146.8M $146.8M FY24FY25: $197.1M $197.1M FY25
Net income
FY19: $2.3M $2.3M FY19FY20: -$10.2M -$10.2M FY20FY20: -$20.5M -$20.5M FY20FY21: -$40.1M -$40.1M FY21FY22: -$27.3M -$27.3M FY22FY23: -$56.1M -$56.1M FY23FY24: -$27.3M -$27.3M FY24FY25: $41.3M $41.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$197.1M-$22.4M$41.3M$0.50-$58.5M
2024$146.8M-$22.5M-$27.3M-$0.35-$33.4M
2023$225.2M-$68.1M-$56.1M-$0.76-$34.5M
2022$146.1M-$53.5M-$27.3M-$0.38-$37.9M
2021$50.5M-$24.1M-$40.1M-$0.93-$15.9M
2020n/a-$678.5K-$20.5M-$2.17n/a

Latest SEC filings

What Strata Critical Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 20, 2026
  2. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 4, 2026
  4. July 8, 2026
  5. June 17, 2026
  6. June 3, 2026
  7. May 8, 2026
  8. May 6, 2026
  9. May 6, 2026
    Quarterly report 10-Q · period to March 31, 2026
  10. May 6, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 25, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SRTA

What does Strata Critical Medical, Inc. do?

Strata Critical Medical, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker SRTA.

Is Strata Critical Medical, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $40.2M on revenue of $256M, a net margin of 15.7%.

How much revenue does Strata Critical Medical, Inc. make?

Over the twelve months to June 30, 2026 Strata Critical Medical, Inc. reported revenue of $256M. That is 136.1% more than a year earlier.

When did Strata Critical Medical, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 25, 2026.

Similar companies

Follow SRTA

Get an email when Strata Critical Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SRTA: get an email when it files

Where the numbers come from

Financial figures are the values Strata Critical Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.